Your browser doesn't support javascript.
loading
STAG1 mutations cause a novel cohesinopathy characterised by unspecific syndromic intellectual disability.
Lehalle, Daphné; Mosca-Boidron, Anne-Laure; Begtrup, Amber; Boute-Benejean, Odile; Charles, Perrine; Cho, Megan T; Clarkson, Amanda; Devinsky, Orrin; Duffourd, Yannis; Duplomb-Jego, Laurence; Gérard, Bénédicte; Jacquette, Aurélia; Kuentz, Paul; Masurel-Paulet, Alice; McDougall, Carey; Moutton, Sébastien; Olivié, Hilde; Park, Soo-Mi; Rauch, Anita; Revencu, Nicole; Rivière, Jean-Baptiste; Rubin, Karol; Simonic, Ingrid; Shears, Deborah J; Smol, Thomas; Taylor Tavares, Ana Lisa; Terhal, Paulien; Thevenon, Julien; Van Gassen, Koen; Vincent-Delorme, Catherine; Willemsen, Marjolein H; Wilson, Golder N; Zackai, Elaine; Zweier, Christiane; Callier, Patrick; Thauvin-Robinet, Christel; Faivre, Laurence.
Afiliação
  • Lehalle D; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Mosca-Boidron AL; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est, Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Begtrup A; Laboratoire de Cytogénétique, Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Boute-Benejean O; Equipe GAD, EA4271, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Charles P; GeneDx, 207 Perry Parkway, Gaithersburg, Maryland, USA.
  • Cho MT; Service de génétique clinique, CHU Lille, Lille, France.
  • Clarkson A; Genetic Department, University Hospital La Pitié Salpêtrière, Paris, France.
  • Devinsky O; GeneDx, 207 Perry Parkway, Gaithersburg, Maryland, USA.
  • Duffourd Y; Department of Clinical Genetics, Cambridge University Hospitals, Cambridge, UK.
  • Duplomb-Jego L; Epilepsy Center, NYU Langone Medical Center, New York, New York, USA.
  • Gérard B; Equipe GAD, EA4271, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Jacquette A; Laboratoire de Cytogénétique, Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Kuentz P; Equipe GAD, EA4271, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Masurel-Paulet A; Laboratoire de biologie moléculaire, CHU Strasbourg, Strasbourg, France.
  • McDougall C; Genetic Department, University Hospital La Pitié Salpêtrière, Paris, France.
  • Moutton S; Laboratoire de Cytogénétique, Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Olivié H; Equipe GAD, EA4271, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Park SM; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Rauch A; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est, Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Revencu N; Clinical Genetics Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Rivière JB; Department of Clinical Genetics, Bordeaux, France.
  • Rubin K; Department of Human Genetics and Centre for Developmental Disabilities, KU University Hospital Leuven, Leuven, Belgium.
  • Simonic I; Department of Clinical Genetics, Cambridge University Hospitals, Cambridge, UK.
  • Shears DJ; Institute of Medical Genetics, University of Zurich, Schwerzenbach-Zurich, Switzerland.
  • Smol T; Centre for Human Genetics, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
  • Taylor Tavares AL; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Terhal P; Laboratoire de Cytogénétique, Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Thevenon J; Equipe GAD, EA4271, Faculté de Médecine, Université de Bourgogne Franche-Comté, Dijon, France.
  • Van Gassen K; University of Minnesota Children's Hospital, Minneapolis, Minnesota, USA.
  • Vincent-Delorme C; Department of Clinical Genetics, Cambridge University Hospitals, Cambridge, UK.
  • Willemsen MH; Oxford Centre for Genomic Medicine Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7HE.
  • Wilson GN; Service de génétique clinique, CHU Lille, Lille, France.
  • Zackai E; Univ. Lille, RADEME (Research team on rare developmental and metabolic diseases), Lille, France.
  • Zweier C; Department of Clinical Genetics, Cambridge University Hospitals, Cambridge, UK.
  • Callier P; Department of Medical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Thauvin-Robinet C; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (TRANSLAD), Centre Hospitalier Universitaire Dijon, Dijon, France.
  • Faivre L; Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est, Centre Hospitalier Universitaire Dijon, Dijon, France.
J Med Genet ; 54(7): 479-488, 2017 07.
Article em En | MEDLINE | ID: mdl-28119487
ABSTRACT

BACKGROUND:

Cohesinopathies are rare neurodevelopmental disorders arising from a dysfunction in the cohesin pathway, which enables chromosome segregation and regulates gene transcription. So far, eight genes from this pathway have been reported in human disease. STAG1 belongs to the STAG subunit of the core cohesin complex, along with five other subunits. This work aimed to identify the phenotype ascribed to STAG1 mutations.

METHODS:

Among patients referred for intellectual disability (ID) in genetics departments worldwide, array-comparative genomic hybridisation (CGH), gene panel, whole-exome sequencing or whole-genome sequencing were performed following the local diagnostic standards.

RESULTS:

A mutation in STAG1 was identified in 17 individuals from 16 families, 9 males and 8 females aged 2-33 years. Four individuals harboured a small microdeletion encompassing STAG1; three individuals from two families had an intragenic STAG1 deletion. Six deletions were identified by array-CGH, one by whole-exome sequencing. Whole-exome sequencing found de novo heterozygous missense or frameshift STAG1 variants in eight patients, a panel of genes involved in ID identified a missense and a frameshift variant in two individuals. The 17 patients shared common facial features, with wide mouth and deep-set eyes. Four individuals had mild microcephaly, seven had epilepsy.

CONCLUSIONS:

We report an international series of 17 individuals from 16 families presenting with syndromic unspecific ID that could be attributed to a STAG1 deletion or point mutation. This first series reporting the phenotype ascribed to mutation in STAG1 highlights the importance of data sharing in the field of rare disorders.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Proteínas Cromossômicas não Histona / Proteínas de Ciclo Celular / Deficiência Intelectual / Mutação Tipo de estudo: Guideline Limite: Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Med Genet Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Proteínas Cromossômicas não Histona / Proteínas de Ciclo Celular / Deficiência Intelectual / Mutação Tipo de estudo: Guideline Limite: Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: J Med Genet Ano de publicação: 2017 Tipo de documento: Article